BDBM484046 2-(3-((S)-2-hydroxy-3- ((R)-8-(quinolin-3- ylsulfonyl)-1-oxa-8- azaspiro[4.5]decan-3- ylamino)propoxy)phenyl sulfonl)acetamide::US10927123, Compound 123

SMILES NC(=O)CS(=O)(=O)c1cccc(OC[C@@H](O)CN[C@H]2COC3(C2)CCN(CC3)S(=O)(=O)c2cnc3ccccc3c2)c1

InChI Key InChIKey=CJNUPIPMYICUTD-YADHBBJMSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 484046   

TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
Arena Pharmaceuticals

US Patent
LigandPNGBDBM484046(2-(3-((S)-2-hydroxy-3- ((R)-8-(quinolin-3- ylsulfo...)
Affinity DataIC50:  5.32E+4nMAssay Description:Compounds were dissolved and serially diluted (5-fold) in DMSO to generate a 10-point dose response stock. The stock was then diluted 100-fold in ass...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent